Torre LA,Bray F,Siegel RL,Anunobi CC,Akinde OR,Elesha SO,Daramola AO,Tijani KH,Ojewola RW .2011 .Prostate diseases in Lagos, Nigeria: a histologic study with tPSA correlation. Nigerian Postgrad Med J, 18(2) : 98-104.
Cancer Society American .2016 .Key statistics for prostate cancer. , : .
Siegel R,Naishadham D,Jemal A .2013 .. CA Cancer J Clin, 63(1) : 11-30.
Barakzai Muhammed Abrar,Iqbal MM,KJ MM .2011 .Histopathological lesions in transrectal ultrasound-guided biopsies of prostate in patients with raised serum prostate-specific antigen: a preliminary report. J Nephro-Urology Monthly, 3(3) : 186-190.
Davnall F,Yip CS,Ljungqvist G,Selmi M,Ng F,Sanghera B,Ganeshan B,Miles KA,Ploussard G,Epstein JI,Montironi R,Carroll PR,Wirth M,Grimm MO .2011 .The contemporary concept of significant versus insignificant prostate cancer. Eur Urol, 60(2) : 291-303.
Mottet N,Bellmunt J,Briers E,van den Bergh RCN,Bolla M,van Casteren NJ .2015 .. Guidelines on Prostate Cancer, : .
Guidelines-ProstateCancer- .2015 .. -v2.pdf. Accessed 1 Dec, : .
Barentsz JO,Richenberg J,Clements R,Choyke P,Verma S,Villeirs G . .ESUR prostate MR guidelines 2012. , : .
Weinreb JC,Barentsz JO,Choyke PL,Cornud F,Haider MA,Macura KJ,Urol Eur .2016 .PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 69(1) : 16-40.
Barentsz JO,Weinreb JC,Verma S,Thoeny HC,Tempany CM,Shtern F .2016 .Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol, 69(1) : 41-9.
Lubner MG,Smith AD,Sandrasegaran K,Sahani DV,Pickhardt PJ,Schieda N,Lim CS,Zabihollahy F .2021 .Quantitative prostate MRI. J Magn Reson Imaging, 53 : 1645-1503.
Lovinfosse P,Polus M,Van Daele D .2018 .FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging, 45 : 375.
Egevad L,Delahunt B,Srigley JR,Samaratunga H. International . .Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading. APMIS., : .
.2016 .-weighted MRI-derived textural features refect prostate cancer aggressiveness: preliminary results. Eur. Radiol., 124 : 433-5.
.2016 .. , : 1.
Vignati A. .2015 .Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys. Med. Biol, 60 : 2685-2701.
Thompson L.C.,Pokorny M.R. Multiparametric .2015 .MRI in the diagnosis of prostate cancer-A generational change. Aust. Fam. Physician, 44 : 597-602.
Fütterer J.J.,S.W. J.J.,T.W. J.J.,J. J.J.,H.J. J.J.,Hulsbergen-Van de Kaa P.,Witjes C.A.,Krabbe J.A.,Heerschap P.F.,A. P.F.,Tanimoto A.,Nakashima J.,H. J.,H. J.,S. J.,Pinto B.,Mani P.A.,H. P.A.,Pang M.,McKinney Y.,Khurana Y.L.,Ravizzini K.,Albert G.C.,P.S. G.C.,M.J. G.C. .2007 .Prostate cancer screening: The clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J. Magn. Reson. Imaging, 25 : 146-152.
.2010 .Prostate cancer: Value of multiparametric MR imaging at 3 T for detection-Histopathologic correlation. Radiology, 255 : 89-99.
K. .2017 .Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J. Magn. Reson. Imaging, 45 : 103-117.
Barrett T,Turkbey B,Choyke PL,Park SY,Jung DC,Oh YT,Tan CH,Wei W,Johnson V,Kundra V .2016 .Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol., 280 : 108.
Weinreb JC,Barentsz JO,Choyke PL,Cornud F,Haider MA,Macura KJ,Margolis D,Schnall MD,Shtern F,Tempany CM,Urol Eur .2016 .PI-RADS prostate imaging - reporting and data system: 2015, Version 2. , 69 : 16-40.